- Real-world clinicopathological characteristics and treatment patterns of esophageal cancer patients in ChinaLu, Z.; Geng, M.; Han, Y.; Cao, J.; Wang, J.; Liu, T.; Yuan, X.; Meng, X.; Zhang, Y.; Zhao, R.; Wan, L.; Li, E.; Wang, W.; Li, Z.; Shi, D. F.; Jing, Q.; Shi, S.; Dong, F.; Shen, L.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), SINGAPORE, 2023-12-01 To 2023-12-03.
- First-line nivolumab (NIVO) plus chemotherapy (chemo) vs chemo in patients with advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): CheckMate 649 Chinese subgroup analysis 2-year follow-upShen, L.; Bai, Y.; Lin, X.; Li, W.; Wang, J.; Zhang, X.; Pan, H.; Bai, C.; Bai, L.; Cheng, Y.; Zhang, J.; Zhong, H.; Ba, Y.; Hu, W.; Xu, R.; Guo, W.; Qin, S.; Yang, N.; Lu, J.; Chanaga, C. Amaya; Soleymani, S.; Liu, T.被引 1
- ASO Visual Abstract: Adjuvant Chemotherapy for Patients with Adenocarcinoma of the Esophagogastric Junction: A Retrospective, Multicenter Observational StudyNie, Run-Cong; Luo, Tian-Qi; Li, Guo-Dong; Zhang, Fei-Yang; Chen, Guo-Ming; Li, Jin-Xing; Chen, Xiao-Jiang; Zhao, Zhou-Kai; Jiang, Kai-Ming; Wei, Yi-Cheng; Hang, Ming-Wei*; Chen, Shi*; Chen, Ying-Bo*Annals of Surgical Oncology, 2023.
会议论文
Treatment patterns and clinical outcomes of patients with unresectable advanced or metastatic (UAM) gastric/gastroesophageal junction adenocarcinoma (GA/GEJA) in China: A multicenter real-world study
15阅读
